Repligen Free Cash Flow Per Share vs Cash Ratio Analysis
RGEN Stock | USD 150.54 0.55 0.37% |
Repligen financial indicator trend analysis is much more than just breaking down Repligen prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Repligen is a good investment. Please check the relationship between Repligen Free Cash Flow Per Share and its Cash Ratio accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.
Free Cash Flow Per Share vs Cash Ratio
Free Cash Flow Per Share vs Cash Ratio Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Repligen Free Cash Flow Per Share account and Cash Ratio. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Repligen's Free Cash Flow Per Share and Cash Ratio is -0.08. Overlapping area represents the amount of variation of Free Cash Flow Per Share that can explain the historical movement of Cash Ratio in the same time period over historical financial statements of Repligen, assuming nothing else is changed. The correlation between historical values of Repligen's Free Cash Flow Per Share and Cash Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Per Share of Repligen are associated (or correlated) with its Cash Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash Ratio has no effect on the direction of Free Cash Flow Per Share i.e., Repligen's Free Cash Flow Per Share and Cash Ratio go up and down completely randomly.
Correlation Coefficient | -0.08 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Free Cash Flow Per Share
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.Cash Ratio
Most indicators from Repligen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Repligen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.At this time, Repligen's Selling General Administrative is very stable compared to the past year. As of the 29th of November 2024, Enterprise Value Over EBITDA is likely to grow to 82.01, while Tax Provision is likely to drop about 7.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 391.3M | 455.7M | 284.2M | 538.9M | Total Revenue | 670.5M | 801.5M | 638.8M | 768.0M |
Repligen fundamental ratios Correlations
Click cells to compare fundamentals
Repligen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Repligen fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.4B | 1.9B | 2.4B | 2.5B | 2.8B | 3.0B | |
Short Long Term Debt Total | 263.3M | 275.4M | 366.1M | 423.0M | 711.8M | 747.4M | |
Other Current Liab | 28.3M | 36.3M | 70.5M | 63.3M | 46.4M | 48.7M | |
Total Current Liabilities | 48.3M | 319.0M | 375.3M | 404.2M | 158.2M | 166.1M | |
Total Stockholder Equity | 5.8M | 65.8M | 1.8B | 397.3M | 2.0B | 2.1B | |
Property Plant And Equipment Net | 74.2M | 92.0M | 226.5M | 315.7M | 323.0M | 339.1M | |
Net Debt | (265.1M) | (441.9M) | (237.8M) | (100.5M) | (39.5M) | (41.5M) | |
Retained Earnings | 5.8M | 65.8M | 194.1M | 397.3M | 438.8M | 460.8M | |
Cash | 528.4M | 717.3M | 603.8M | 523.5M | 751.3M | 788.9M | |
Non Current Assets Total | 758.3M | 1.0B | 1.4B | 1.5B | 1.7B | 1.8B | |
Non Currrent Assets Other | 238K | 573K | 615K | 815K | 1.3M | 1.3M | |
Cash And Short Term Investments | 528.4M | 717.3M | 603.8M | 623.8M | 751.3M | 788.9M | |
Net Receivables | 43.7M | 71.4M | 117.4M | 116.2M | 124.2M | 130.4M | |
Common Stock Shares Outstanding | 49.2M | 53.9M | 57.3M | 57.5M | 56.4M | 29.9M | |
Liabilities And Stockholders Equity | 346.2M | 439.5M | 2.4B | 1.0B | 2.8B | 3.0B | |
Non Current Liabilities Total | 292.0M | 54.8M | 233.0M | 209.8M | 695.0M | 729.8M | |
Inventory | 54.8M | 95.0M | 184.5M | 238.3M | 202.3M | 212.4M | |
Other Current Assets | 3.1M | 18.7M | 25.9M | 19.8M | 33.2M | 34.9M | |
Other Stockholder Equity | 14.5M | 1.5B | 1.6B | 1.5B | 1.6B | 1.6B | |
Total Liab | 340.3M | 373.7M | 608.3M | 614.0M | 853.2M | 895.9M | |
Property Plant And Equipment Gross | 74.2M | 92.0M | 297.2M | 408.0M | 451.7M | 474.3M | |
Total Current Assets | 641.8M | 902.4M | 931.7M | 998.1M | 1.1B | 1.2B | |
Accumulated Other Comprehensive Income | (15.0M) | 2.1M | (16.9M) | (34.4M) | (37.4M) | (35.6M) | |
Accounts Payable | 11.4M | 16.9M | 36.2M | 27.6M | 19.6M | 20.5M | |
Short Term Debt | 3.6M | 249.0M | 263.6M | 291.6M | 75.1M | 101.1M | |
Other Assets | 3.2M | 28.2M | 2.5M | 1.7M | 1.5M | 1.6M | |
Common Stock Total Equity | 521K | 548K | 553K | 556K | 639.4K | 389.2K | |
Common Stock | 521K | 548K | 553K | 556K | 558K | 398.5K | |
Property Plant Equipment | 48.5M | 66.9M | 125.0M | 190.7M | 219.3M | 230.2M | |
Other Liab | 32.3M | 28.4M | 130.5M | 78.4M | 90.1M | 94.6M | |
Current Deferred Revenue | 5.0M | 15.3M | 14.8M | 19.3M | 10.3M | 5.4M | |
Good Will | 468.4M | 618.3M | 860.4M | 855.5M | 987.1M | 1.0B | |
Intangible Assets | 212.6M | 287.1M | 337.3M | 353.7M | 400.5M | 420.5M | |
Net Tangible Assets | 378.8M | 623.7M | 552.4M | 701.5M | 806.7M | 847.1M | |
Retained Earnings Total Equity | 5.8M | 65.8M | 194.1M | 397.3M | 456.9M | 479.7M | |
Capital Surpluse | 1.1B | 1.5B | 1.6B | 1.5B | 1.8B | 1.9B |
Pair Trading with Repligen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Repligen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Repligen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Repligen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Repligen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Repligen to buy it.
The correlation of Repligen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Repligen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Repligen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Repligen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.83) | Earnings Share (0.03) | Revenue Per Share 11.452 | Quarterly Revenue Growth 0.097 | Return On Assets 0.002 |
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.